B-cell acute lymphoblastic leukemia (B-ALL): a report of 17 pediatric cases

Haematologica. 1992 Mar-Apr;77(2):151-5.

Abstract

Background and methods: B-cell acute lymphoblastic leukemia (B-ALL) presents FAB L3 morphology and surface Ig, CD19, CD20, CD24. This pattern may show some morphological and immunological heterogeneity. Seventeen pediatric cases of B-ALL at onset, treated in twelve AIEOP Centers (Italian Association for Pediatric Hematology and Oncology), are presented.

Results and conclusions: Clinical and hematological features were characterized by low WBC counts at presentation, high M/F ratio, older age and association with extramedullary involvement. The overall survival curve at 78 months is 40%. All patients showed blasts positive for surface Ig (sIg), DR, CD19, and CD24. Ten/17 cases presented the classical features of B-ALL: FAB L3 morphology, sIg+ restricted to light chains, CD20+, cytoplasm mu (c mu)-, CD10-, TdT-. The remainder showed some differences in this pattern, such as non-L3 morphology (3 cases), absence of CD20 (3 cases), CD10+ (4 cases), TdT+ (3 cases), c mu+ (1 case), lack of surface light chains (1 case). This rare ALL subset seems to be characterized by a high phenotype heterogeneity, indicating various degrees of differentiation.

MeSH terms

  • Adolescent
  • Antigens, Neoplasm / analysis
  • Biomarkers, Tumor / analysis
  • Burkitt Lymphoma / epidemiology*
  • Burkitt Lymphoma / immunology
  • Burkitt Lymphoma / pathology
  • Cell Differentiation
  • Child
  • Child, Preschool
  • Chromosome Aberrations
  • Female
  • Humans
  • Immunophenotyping
  • Incidence
  • Italy / epidemiology
  • Life Tables
  • Male
  • Neoplasm Proteins / analysis
  • Prognosis
  • Survival Analysis
  • Treatment Outcome

Substances

  • Antigens, Neoplasm
  • Biomarkers, Tumor
  • Neoplasm Proteins